|
PRUNE expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.2217000178747E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
9.784700E-03 |
| Stage1-vs-Stage3 |
1.575830E-01 |
| Stage1-vs-Stage4 |
3.363900E-03 |
| Stage2-vs-Stage3 |
1.341770E-03 |
| Stage2-vs-Stage4 |
1.419190E-04 |
| Stage3-vs-Stage4 |
1.675830E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.91859999793587E-09 |
| Normal-vs-Asian |
1.62458935193399E-12 |
| Caucasian-vs-AfricanAmerican |
1.494430E-01 |
| Caucasian-vs-Asian |
3.870600E-01 |
| AfricanAmerican-vs-Asian |
1.101970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.272800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.65013999999797E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.308000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.021400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.691600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.747200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.945200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.842800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.43636230581978E-12 |
| Classical-VS-Follicular |
7.58839999726035E-08 |
| Classical-VS-Other |
5.513400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
<1E-12 |
| Tall-VS-Other |
6.335800E-02 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
2.172000E-01 |
| Follicular-VS-Normal |
1.94359994765136E-09 |
| Other-VS-Normal |
1.015440E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
4.52389999905378E-08 |
|
|
